| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$12 |
H1 FY25 Results Announcement
|
27 Feb 2025 8:43AM |
$0.032 |
$0.023 |
fallen by
28.13%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- $26.2m in H1 revenue – up 22.3% YoY
- 29% decrease in H1 FY25 opex YoY
- 97% YoY improvement in H1 EBITDA to ($0.36m)
- 2024 cost out program fully implemented – full benefits from H2 FY25
- Business streamlined with sale of International Bank of Australia interest for $2.87m
- Balance sheet strengthened with removal of legacy liabilities and capital raising
- Remain on track to achieve positive operating cashflow for the half-year ending June 2025
- $6.25m cash at end of H1 FY25
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Goodman Group (GMG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$70,217 |
Security Purchase Plan
|
27 Feb 2025 8:43AM |
$32.150 |
$34.570 |
risen by
7.53%
|
|
| Mad Paws Holdings Limited (MPA) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
1H FY 2025 Results Announcement
|
27 Feb 2025 8:42AM |
$0.079 |
$0.064 |
fallen by
18.99%
|
|
MPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Group Operating Revenues of $14.7 million - flat on pcp, and +11% excluding Sash and Waggly
- Marketplace Operating Revenue of $4.8 million – up 12% on pcp
- E-Commerce Revenue of $9.9 million – down 5% on pcp, +11% excluding Sash and Waggly
- Achieved Group Cash EBITDA positive for 1H FY25 of $0.3 million +172% on pcp
- Segment Operating EBITDA positive at $2.2 million, +76% on pcp
- Marketplace Cash EBITDA of $2.2 million up from $1.7 million in the pcp, with an EBITDA margin of 45.8%
- Ecommerce & Subscription Cash EBITDA break-even for 1H FY25, +$0.5 million on pcp
- Strong momentum across core businesses with $1.9 million remaining in SWM media contra
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$12 |
Appendix 4D Half Year Report and Accounts
|
27 Feb 2025 8:41AM |
$0.032 |
$0.023 |
fallen by
28.13%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 22.3% to $26.2 million.
- Loss after tax attributable to owners decreased to $2.02 million.
- Significant gains from discontinued operations amounting to $3.02 million.
- Ongoing strategic efforts to streamline operations and focus on higher-margin services.
- Successful capital raise of $7 million to fund growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
TruScreen Signs MOU with Hangzhou Dalton Bioscience
|
27 Feb 2025 8:41AM |
$0.028 |
$0.017 |
fallen by
39.29%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TruScreen signed a non-binding MOU with Hangzhou Dalton Bioscience.
- The MOU aims to expand TruScreen's HPV related product portfolio.
- Collaboration will enhance access to cervical cancer screening solutions.
- TruScreen plans to negotiate a formal distribution agreement within three months.
- The collaboration consists of a short-term and medium-to-long-term phase.
- TruScreen's CEO emphasized the partnership's significance for global healthcare solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mad Paws Holdings Limited (MPA) ORDINARY FULLY PAID |
Consumer Discretionary |
$26 |
Appendix 4D and Half Year Report FY 2025
|
27 Feb 2025 8:41AM |
$0.079 |
$0.064 |
fallen by
18.99%
|
|
MPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue increased by 0.6% to $14,767,884.
- Loss after tax increased by 78.9% to $3,871,571.
- Group Cash EBITDA improved by $0.7 million compared to the previous year.
- Successful media campaign launched in partnership with Seven West Media.
- Marketplace division saw a 12% increase in operating revenue.
- e-Commerce division achieved EBITDA break-even for the first time.
- No dividends were paid, recommended, or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$5 |
Notice of General Meeting/Proxy Form
|
27 Feb 2025 8:41AM |
$0.012 |
$0.007 |
fallen by
41.67%
|
|
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$568 |
Appendix 4G
|
27 Feb 2025 8:40AM |
$1.470 |
$1.420 |
fallen by
3.40%
|
|
| Red Hawk Mining Limited (RHK) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holding from FMG
|
27 Feb 2025 8:40AM |
$1.200 |
$1.200 |
fallen by
0%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$45,230 |
Change in substantial holding for RHK
|
27 Feb 2025 8:40AM |
$16.860 |
$14.690 |
fallen by
12.87%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,096 |
Corporate Presentation and Half Year Financial Results
|
27 Feb 2025 8:40AM |
$2.460 |
$1.640 |
fallen by
33.33%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Mesoblast is committed to innovative cellular medicines for serious inflammatory illnesses.
- The company is a leader in allogeneic cellular medicines with facilities in Australia, the U.S., and Singapore.
- RYONCIL is the first FDA-approved cell therapy for pediatric patients with SR-aGvHD.
- REVASCOR received multiple designations from the FDA for hypoplastic left heart syndrome.
- Mesoblast anticipates significant advancements in its product pipeline over the next six to twelve months.
- The company has a strong intellectual property portfolio with over 1,100 patents and applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$28,825 |
Coles Chair Succession
|
27 Feb 2025 8:39AM |
$19.690 |
$21.490 |
risen by
9.14%
|
|
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$12 |
Application for quotation of securities - AAU
|
27 Feb 2025 8:37AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,096 |
Half Year Report and Accounts (including Appendix 4D)
|
27 Feb 2025 8:37AM |
$2.460 |
$1.640 |
fallen by
33.33%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 7% to $3.156 million.
- Net loss attributable to members increased by 47% to $47.934 million.
- Total cash reserves as of December 31, 2024, were $38 million.
- A global private placement raised $161 million in January 2025.
- The company focuses on commercializing Ryoncil for pediatric patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,281 |
Wide, high grade gold zones confirmed at Scotia
|
27 Feb 2025 8:37AM |
$0.135 |
$3.260 |
risen by
2,314.81%
|
|
PNR - Price-sensitive ASX Announcement
Full Release
Key Points
- Wide high-grade gold zones confirmed at Scotia.
- 83 grade control holes completed at the Scotia orebody.
- Multiple zones of high-grade gold mineralization identified.
- Potential for expansion of the mine plan indicated.
- Development in first three levels confirmed mineralization outside the current Ore Reserve.
- Transitioning Scotia to a production-focused mine.
- Steady-state operations targeted by the end of March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$11 |
1H FY25 Results Presentation
|
27 Feb 2025 8:36AM |
$0.071 |
$0.060 |
fallen by
15.49%
|
|
ODA - Price-sensitive ASX Announcement
Full Release
Key Points
- Transport SaaS revenue increased by 56% compared to 1H FY24.
- Total income for 1H FY25 was $9.5 million, down 34% from 1H FY24.
- EBITDA was $(0.5) million, a decline from $1.5 million in the previous year.
- Net profit after tax was $(1.5) million.
- The Infrastructure Services division saw a 53% drop in revenue.
- Orcoda is focusing on customer diversification and expanding SaaS capabilities.
- Cost management strategies included redundancies and controlled expenditures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$2 |
Section 708A Notice
|
27 Feb 2025 8:36AM |
$0.004 |
$0.002 |
fallen by
50%
|
|
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$11 |
1H FY25 Results Summary
|
27 Feb 2025 8:35AM |
$0.071 |
$0.060 |
fallen by
15.49%
|
|
ODA - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H FY25 total income was $9.5 million, down 34% year-on-year.
- Transport Technology division saw SaaS revenue growth of 56% compared to the previous period.
- Annual Recurring Revenue (ARR) at $4.5 million, an 11% increase.
- Betta Group's revenue declined due to largest customer deferring works program.
- The company recorded positive net operating cash flows each quarter.
- Orcoda ended the half with cash and cash equivalents of $3.1 million.
- Outlook remains positive with expectations for continued growth in Transport Technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$63 |
1HFY25 Investor Presentation
|
27 Feb 2025 8:35AM |
$0.225 |
$0.220 |
fallen by
2.22%
|
|
ATG - Price-sensitive ASX Announcement
Full Release
Key Points
- Solid progress against FY25 priorities.
- TeePublic gross profit margin up 80 bps on 1HFY24.
- On track to deliver positive underlying cash flow in FY25.
- Launched Dashery to enable creators to launch custom storefronts.
- Combined marketplace operations to optimize performance.
- Expecting $12 million to $14 million in annualized savings from restructuring.
- Redbubble gross profit margin increased by 330 bps on 1HFY24.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$28,825 |
2025 Half Year Results Presentation
|
27 Feb 2025 8:34AM |
$19.690 |
$21.490 |
risen by
9.14%
|
|
COL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 3.7% to $23.035 billion.
- Underlying EBITDA rose by 12.5% to $2.137 billion.
- The company focused on value campaigns and strategic priorities.
- Strong eCommerce sales growth, particularly in the on-demand channel.
- Inflationary pressures impacted EBIT margins.
- Significant investments in automation and digital transformation.
- Coles demonstrated resilience in supply chain operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beforepay Group Limited (B4P) ORDINARY FULLY PAID |
Financials |
$72 |
H1 FY25 Investor Presentation
|
27 Feb 2025 8:34AM |
$1.280 |
$1.500 |
risen by
17.19%
|
|
B4P - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY25 revenue of A$19.67 million
- Net transaction margin increased by 18% to A$11.8 million
- Net defaults reduced to 1.1%
- Strong cash position of A$18.3 million as of December 31, 2024
- Use of AI technology to enhance lending practices
- Expansion in customer base
- Efficient management of operational costs
- Commitment to ethical lending
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kogan.com Ltd (KGN) ORDINARY FULLY PAID |
Consumer Discretionary |
$370 |
Update - Notification of buy-back - KGN
|
27 Feb 2025 8:34AM |
$4.900 |
$3.730 |
fallen by
23.88%
|
|
| SenSen Networks Limited (SNS) ORDINARY FULLY PAID |
Information Technology |
$23 |
Appendix 4D and Half Year Report
|
27 Feb 2025 8:34AM |
$0.036 |
$0.029 |
fallen by
19.44%
|
|
SNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $5,483,322 increased 1% from the previous year.
- Net loss reduced to $1,592,949 from $2,062,306.
- Successful contract wins in Calgary and Montreal.
- Operating costs decreased by $523,783, or 7%.
- Achieved third consecutive cash flow positive quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$13,439 |
Appendix 3X - Initial Director's Interest Notice - P Winn
|
27 Feb 2025 8:34AM |
$5.080 |
$5.600 |
risen by
10.24%
|
|
| Metrics Master Income Trust (MXT) ORDINARY UNITS FULLY PAID |
Financials |
$2,437 |
Appendix 4D and Half Year Accounts
|
27 Feb 2025 8:34AM |
$2.090 |
$1.995 |
fallen by
4.55%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
